Clinical Trials Browser

Phase 2 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × pegylated granulocyte colony-stimulating factor × Clear all

NCT07224100 2026-04-16

Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma

Phase 2 Recruiting

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma